Tomohide Hori, Taku Iida, Shintaro Yagi, Kentaro Taniguchi, Chiduru Yamamoto, Shugo Mizuno, Kentaro Yamagiwa, Shuji Isaji, Shinji Uemoto – 22 March 2006 – Reliable monitoring enabling evaluation of graft function is crucial after living‐donor liver transplantation (LDLT). A method to identify poor graft function at an early postoperative period would allow opportune intensive clinical management to bring about further improvements in LDLT outcomes.

Francesco Menichetti, Maria Lucia Bindi, Carlo Tascini, Lucio Urbani, Gianni Biancofiore, Roberta Doria, Massimo Esposito, Roberto Mozzo, Gabriele Catalano, Franco Filipponi – 22 March 2006 – A case of post‐transplant malaria is described. The patient presented fever and severe anemia after orthotopic liver transplantation. Diagnosis was made only after the review of donor characteristics. Although a high parasitemia was found at the moment of diagnosis, the treatment with quinine and doxycycline was successful.

Paul Angulo – 22 March 2006 – Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurrence rate of disease. This paper reviews the prevalence of nonalcoholic fatty liver disease, its progressive potential, and the implications of this liver condition in both the pre‐ and post‐liver transplantation setting. Liver Transpl 12:523–534, 2006.

22 March 2006

Marina Berenguer – 22 March 2006

Linsheng Guo, Mauricio Orrego, Hector Rodriguez‐Luna, Vijiyan Balan, Thomas Byrne, Kapil Chopra, David D. Douglas, Edwyn Harrison, Adyr Moss, K. Sudhakar Reddy, James W. Williams, Jorge Rakela, David Mulligan, Hugo E. Vargas – 22 March 2006 – The question of possible earlier and more aggressive recurrence of hepatitis C virus (HCV) infection after living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) remains unanswered.

Benjamin L. Shneider, Sukru Emre – 22 March 2006

James D. Perkins – 22 March 2006

22 March 2006

Jeane M. Tsutsui, Sandeep Mukherjee, Abdou Elhendy, Feng Xie, Elizabeth R. Lyden, Edward O'Leary, Anna C. McGrain, Thomas R. Porter – 22 March 2006 – Although dobutamine stress echocardiography has been used for the preoperative evaluation of patients with advanced liver disease (ALD), no data exist regarding the value of myocardial perfusion imaging (MPI) with real‐time myocardial contrast echocardiography (RTMCE) in this patient population. We sought to determine the value of MPI during dobutamine stress RTMCE for predicting prognosis in patients with ALD.